Wolverine Trading
NVCR icon

Wolverine Trading’s NovoCure NVCR Stock Holding History

Wolverine Trading’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,799
Closed -$223K – 5494
2024
Q4 		$295K Buy
+9,799
New +$207K ﹤0.01% 4039
2024
Q2 		– Sell
-11,668
Closed -$205K – 4998
2024
Q1 		$182K Buy
+11,668
New +$172K ﹤0.01% 3844
2023
Q3 		– Sell
-6,727
Closed -$194K – 4910
2023
Q2 		$271K Buy
+6,727
New +$418K ﹤0.01% 3212
2023
Q1 		– Sell
-15,535
Closed -$1.24M – 4724
2022
Q4 		$1.14M Buy
15,535
+3,655
+31% +$275K ﹤0.01% 1745
2022
Q3 		$915K Buy
11,880
+648
+6% +$50.5K ﹤0.01% 2049
2022
Q2 		$813K Sell
11,232
-461
-4% -$34.7K ﹤0.01% 2097
2022
Q1 		$983K Buy
11,693
+1,828
+19% +$135K ﹤0.01% 2451
2021
Q4 		$788K Buy
9,865
+107
+1% +$10.7K ﹤0.01% 2905
2021
Q3 		$1.13M Sell
9,758
-10,242
-51% -$1.55M ﹤0.01% 2832
2021
Q2 		$4.48M Buy
20,000
+7,969
+66% +$1.55M 0.01% 1243
2021
Q1 		$1.51M Buy
+12,031
New +$1.9M ﹤0.01% 2249
2020
Q3 		– Sell
-18,506
Closed -$1.48M – 4949
2020
Q2 		$1.07M Sell
18,506
-9,381
-34% -$617K ﹤0.01% 1941
2020
Q1 		$1.95M Sell
27,887
-10,101
-27% -$798K 0.01% 1358
2019
Q4 		$3.24M Buy
37,988
+28,089
+284% +$2.27M 0.01% 1447
2019
Q3 		$727K Sell
9,899
-4,567
-32% -$365K ﹤0.01% 2245
2019
Q2 		$915K Buy
+14,466
New +$733K ﹤0.01% 2126
2018
Q4 		– Sell
-25,298
Closed -$925K – 5073
2018
Q3 		$1.33M Buy
25,298
+9,721
+62% +$387K ﹤0.01% 2044
2018
Q2 		$340K Hold
15,577
– – ﹤0.01% 3605
2018
Q1 		$340K Buy
+15,577
New +$335K ﹤0.01% 3605
2016
Q3 		– Sell
-12,732
Closed -$116K – 4951
2016
Q2 		$145K Buy
+12,732
New +$159K ﹤0.01% 3471

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's NVCR Position: Q1 2025 in Review

Wolverine Trading sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 9,799 shares — an estimated $223K sold.

Wolverine Trading first reported a position in NVCR in Q2 2016 and held it in 20 quarters. The position peaked at $4.48M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.

  • Wolverine Trading reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 9,799 NovoCure shares in Q1 2025, an estimated $223K.
  • Wolverine Trading first reported a position in NovoCure in Q2 2016 and held it in 20 quarters.
  • Wolverine Trading's NovoCure position peaked at $4.48M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.